Search Within

Mark E Robson

  1. "Surgery"
Formats
  1. Journal Article (111)
  2. Meeting Abstract (70)
  3. Miscellaneous (3)
  4. Review (2)
  5. Book Section (1)
  6. Editorial (1)
Groups
  1. Breast Medicine Service (188)
  2. Department of Medicine (188)
  3. Population Sciences Research Program (188)
  4. Solid Tumor Oncology Division (188)
  5. Surgery (188)
  6. Survivorship Research (188)

More Groups

People
  1. Kenneth Offit (108)
  2. Noah Kauff (54)
  3. Zsofia Stadler (51)
  4. Larry Norton (34)
  5. Vijai Joseph (30)
  6. Diana Mandelker (29)

More People

Years
  1. 2024 (7)
  2. 2023 (14)
  3. 2022 (13)
  4. 2021 (10)
  5. 2020 (7)
  6. 2019 (18)

More Years

Publications
  1. Journal of Clinical Oncology (47)
  2. Annals of Surgical Oncology (13)
  3. Breast Cancer Research and Treatment (12)
  4. Clinical Cancer Research (10)
  5. Gynecologic Oncology (9)
  6. Cancer Research (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (52)
  2. Springer (30)
  3. American Association for Cancer Research (23)
  4. Nature Publishing Group (19)
  5. Elsevier Inc. (17)
  6. Oxford University Press (9)

More Publishers

Results (188)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
    Meeting Abstract

    Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Are endometrial cancers arising in BRCA1/BRCA2 germline mutations carriers true BRCA1/BRCA2 cancers?
    Meeting Abstract

    Da Cruz Paula, A.; Smith, E.; Cadoo, K.; Abu-Rustum, N.; Pei, X.; Riaz, N.; Robson, M.; Reis-Filho, J.; Mandelker, D.; Weigelt, B.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Clinicopathologic features of breast cancers with HER2/CEP17 ratio <2, HER2 copy number ≥ 4 and <6 signals/cell
    Meeting Abstract

    Xu, J.; Brogi, E.; Ventura, K.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Impact of the 2018 ASCO/CAP HER2 guideline updates on HER2 assessment in breast cancer with HER2 immunohistochemistry equivocal results
    Meeting Abstract

    Wen, H.; Ventura, K.; Xu, J.; Ross, D.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Brogi, E.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Are endometrial cancers arising in BRCA1/BRCA2 germline mutations carriers true BRCA1/BRCA2 cancers?
    Meeting Abstract

    Da Cruz Paula, A.; Smith, E.; Cadoo, K.; Abu-Rustum, N.; Pei, X.; Riaz, N.; Robson, M.; Reis-Filho, J.; Mandelker, D.; Weigelt, B.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Pilot study of rapid MR pancreas screening for patients with BRCA mutation
    Journal Article

    Corrias, G.; Raeside, M. C.; Agostini, A.; Huicochea-Castellanos, S.; Aramburu-Nunez, D.; Paudyal, R.; Shukla-Dave, A.; Smelianskaia, O.; Capanu, M.; Zheng, J.; more...
    European Radiology (2019)

    Fulltext@MSK | Save
  • Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy
    Journal Article

    Krystel-Whittemore, M.; Xu, J.; Brogi, E.; Ventura, K.; Patil, S.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; more...
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Differences between screen-detected and interval breast cancers among BRCA mutation carriers
    Journal Article

    Pilewskie, M.; Zabor, E. C.; Gilbert, E.; Stempel, M.; Petruolo, O.; Mangino, D.; Robson, M.; Jochelson, M. S.
    Breast Cancer Research and Treatment (2019)

    Fulltext@MSK | Save
  • Microsatellite instability is associated with the presence of Lynch syndrome pan-cancer
    Journal Article

    Latham, A.; Srinivasan, P.; Kemel, Y.; Shia, J.; Bandlamudi, C.; Mandelker, D.; Middha, S.; Hechtman, J.; Zehir, A.; Dubard-Gault, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Differences between screen-detected and interval breast cancers among BRCA mutation carriers
    Meeting Abstract

    Pilewskie, M. L.; Zabor, E. C.; Stempel, M.; Petruolo, O.; Mangino, D.; Robson, M. E.; Jochelson, M. S.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save